Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yuko Ikegami is active.

Publication


Featured researches published by Yuko Ikegami.


Journal of Immunology | 2000

Cell Death-Associated Translocation of Plasma Membrane Components Induced by CTL

Yukishige Kawasaki; Takako Saito; Yoshiko Shirota-Someya; Yuko Ikegami; Hajime Komano; Mi-Heon Lee; Christopher J. Froelich; Nobukata Shinohara; Hajime Takayama

In the very early stages of target cell apoptosis induced by CTL, we found that fluorescence of labeling probes of the target plasma membrane, such as N-(3-triethylammoniumpropyl)-4-(p-dibutylaminostyryl)pyridinium dibromide (FM1-43), was translocated into intracellular membrane structures including nuclear envelope and mitochondria. This translocation was associated with the execution of CTL-mediated killing, because neither the CTL-target conjugation alone nor the binding of noncytotoxic Th2 clone with target cell was sufficient to provoke the process. Although FM1-43 translocation was observed in perforin-mediated cytotoxicity, examinations with several other dyes failed to detect the evidence for membrane damages that may cause influx of the dye. Moreover, the translocation was also observed in Fas-dependent apoptosis. These data indicate that the translocation precedes the damage of plasma membrane and intracellular organella in the course of apoptotic cell death and may represent the existence of a membrane trafficking that mediates the translocation of plasma membrane components in the early onset of apoptotic cell death.


Development Genes and Evolution | 1996

Genetic interactions of pokkuri with seven in absentia, tramtrack and downstream components of the sevenless pathway in R7 photoreceptor induction in Drosophila melanogaster

Daisuke Yamamoto; Itsuko Nihonmatsu; Takashi Matsuo; Hiroshi Miyamoto; Shunzo Kondo; Kanako Hirata; Yuko Ikegami

The sevenless (sev) cascade plays an inductive role in formation of the R7 photoreceptor, whilst the pokkuri (pok) and tramtrack (ttk) gene products are known to repress R7 induction in developing ommatidia of Drosophila melanogaster. To elucidate how these positive and negative signalling mechanisms co-operate in the normal fate determination of R7, genetic interactions of mutations in the pok locus with ttk and downstream elements of sev including Gap1, raf1, rolled (r1) and seven in absentia (sina) were examined. The eye phenotype of a weak hypomorph, pok15, was enhanced dominantly by Gap1-mip, a recessive mutation in a gene encoding a down-regulator of Ras1, producing multiple R7 in ommatidia. Ras1 has been reported to activate r1-encoded mitrogen-activated protein (MAP) kinase via Raf1 that is associated physically with Rasl. Ommatidia of raf1c110 and rl2/rlEMS64 typically lacked R7 and a few outer photoreceptors. The pok1 mutation suppressed dominantly the raflc110 rl2/rlEMS64 eye phenotypes, allowing single R7 cells to develop in ommatidia. The raflc110 mutation improved adult viability of pok1 homozygotes. An in vitro experiment demonstrated that MAP kinase phosphorylates Pok protein. Ttk is a transcriptional repressor which binds to the regulatory sequence upstream of the fushi-tarazu (ftz), even skipped (eve) and engrailed (en) coding region. A reduced activity in ttk resulted in enhancement of the pok phenotype. ttk mutations produced extra R7 cells even in sina homozygotes whilst the pok mutation did not. This result indicates that Ttk represses R7 induction downstream of the sites where Pok and Sina function.


Journal of Biological Chemistry | 1991

Activator proteins for glycosphingolipid hydrolysis by endoglycoceramidases. Elucidation of biological functions of cell-surface glycosphingolipids in situ by endoglycoceramidases made possible using these activator proteins.

Makoto Ito; Yuko Ikegami; Tatsuya Yamagata


International Immunology | 1999

Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells

Hajime Komano; Yuko Ikegami; Minesuke Yokoyama; Rika Suzuki; Shin Yonehara; Yoshiki Yamasaki; Nobukata Shinohara


FEBS Journal | 1993

Specific hydrolysis of intact erythrocyte cell-surface glycosphingolipids by endoglycoceramidase : lack of modulation of erythrocyte glucose transporter by endogenous glycosphingolipids

Makoto Ito; Yuko Ikegami; Tadashi Tai; Tatuya Yamagata


FEBS Journal | 1993

Kinetics of endoglycoceramidase action toward cell-surface glycosphingolipids of erythrocytes

Makoto Ito; Yuko Ikegami; Tatuya Yamagata


Molecular Immunology | 2005

Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis.

Aya Yokota; Emiko Takeuchi; Misao Iizuka; Yuko Ikegami; Hajime Takayama; Nobukata Shinohara


Journal of Biological Chemistry | 2000

Coreceptor Function of Mutant Human CD4 Molecules without Affinity to gp120 of Human Immunodeficiency Virus

Makoto Tachibana; Mushtaq A. Siddiqi; Yuko Ikegami; Koji Eshima; Yoshiko Shirota-Someya; Satoko Tahara-Hanaoka; Atsushi Koito; Misao Iizuka; Nobukata Shinohara


Journal of Acquired Immune Deficiency Syndromes | 1997

Comparative analysis of the gp120-binding area of murine and human CD4 molecules.

Mushtaq A. Siddiqi; Makoto Tachibana; Sachiko Ohta; Yuko Ikegami; Satoko Tahara-Hanaoka; Yi-Ying Huang; Nobukata Shinohara


Journal of Biochemistry | 1991

Conversion of Endoglycoceramidase-Activator II by Trypsin to the 27.9 kDa Polypeptide Possessing Full Activity: Purification of Activator for Endoglycoceramidase by Trypsin Treatment Followed by Trypsin-Inhibitor Agarose Column Application

Makoto Ito; Yuko Ikegami; Akira Omori; Tatsuya Yamagata

Collaboration


Dive into the Yuko Ikegami's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge